156 related articles for article (PubMed ID: 17474146)
1. Proteomic exploitation on prothymosin alpha-induced mononuclear cell activation.
Skopeliti M; Kratzer U; Altenberend F; Panayotou G; Kalbacher H; Stevanovic S; Voelter W; Tsitsilonis OE
Proteomics; 2007 Jun; 7(11):1814-24. PubMed ID: 17474146
[TBL] [Abstract][Full Text] [Related]
2. Prothymosin alpha immunoactive carboxyl-terminal peptide TKKQKTDEDD stimulates lymphocyte reactions, induces dendritic cell maturation and adopts a beta-sheet conformation in a sequence-specific manner.
Skopeliti M; Iconomidou VA; Derhovanessian E; Pawelec G; Voelter W; Kalbacher H; Hamodrakas SJ; Tsitsilonis OE
Mol Immunol; 2009 Feb; 46(5):784-92. PubMed ID: 18976813
[TBL] [Abstract][Full Text] [Related]
3. The immunologically active site of prothymosin alpha is located at the carboxy-terminus of the polypeptide. Evaluation of its in vitro effects in cancer patients.
Skopeliti M; Voutsas IF; Klimentzou P; Tsiatas ML; Beck A; Bamias A; Moraki M; Livaniou E; Neagu M; Voelter W; Tsitsilonis OE
Cancer Immunol Immunother; 2006 Oct; 55(10):1247-57. PubMed ID: 16453152
[TBL] [Abstract][Full Text] [Related]
4. Ovarian malignant ascites-derived lymphocytes stimulated with prothymosin α or its immunoactive decapeptide lyse autologous tumour cells in vitro and retard tumour growth in SCID mice.
Voutsas IF; Pistamaltzian N; Tsiatas ML; Skopeliti M; Katsila T; Mavrothalassiti I; Spyrou S; Dimopoulos MA; Tsitsilonis OE; Bamias A
Eur J Cancer; 2013 May; 49(7):1706-14. PubMed ID: 23276721
[TBL] [Abstract][Full Text] [Related]
5. Intracellular and extracellular cytokine-like functions of prothymosin α: implications for the development of immunotherapies.
Mosoian A
Future Med Chem; 2011 Jul; 3(9):1199-208. PubMed ID: 21806381
[TBL] [Abstract][Full Text] [Related]
6. Prothymosin α and a prothymosin α-derived peptide enhance T(H)1-type immune responses against defined HER-2/neu epitopes.
Ioannou K; Derhovanessian E; Tsakiri E; Samara P; Kalbacher H; Voelter W; Trougakos IP; Pawelec G; Tsitsilonis OE
BMC Immunol; 2013 Sep; 14():43. PubMed ID: 24053720
[TBL] [Abstract][Full Text] [Related]
7. Prothymosin Alpha and Immune Responses: Are We Close to Potential Clinical Applications?
Samara P; Ioannou K; Tsitsilonis OE
Vitam Horm; 2016; 102():179-207. PubMed ID: 27450735
[TBL] [Abstract][Full Text] [Related]
8. [Prothymosin alpha and tumor: current status and perspective].
Wang M; Pan JY
Ai Zheng; 2007 Mar; 26(3):333-6. PubMed ID: 17355803
[TBL] [Abstract][Full Text] [Related]
9. Effects of zinc binding on the structure and dynamics of the intrinsically disordered protein prothymosin alpha: evidence for metalation as an entropic switch.
Yi S; Boys BL; Brickenden A; Konermann L; Choy WY
Biochemistry; 2007 Nov; 46(45):13120-30. PubMed ID: 17929838
[TBL] [Abstract][Full Text] [Related]
10. Prothymosin-alpha plays a defensive role in retinal ischemia through necrosis and apoptosis inhibition.
Fujita R; Ueda M; Fujiwara K; Ueda H
Cell Death Differ; 2009 Feb; 16(2):349-58. PubMed ID: 18989338
[TBL] [Abstract][Full Text] [Related]
11. On the anomalous behaviour on gel-filtration and SDS-electrophoresis of prothymosin-alpha.
Cordero OJ; Sarandeses CS; Lopez JL; Nogueira M
Biochem Int; 1992 Dec; 28(6):1117-24. PubMed ID: 1290467
[TBL] [Abstract][Full Text] [Related]
12. Proteomic map of peripheral blood mononuclear cells.
Vergara D; Chiriacò F; Acierno R; Maffia M
Proteomics; 2008 May; 8(10):2045-51. PubMed ID: 18491318
[TBL] [Abstract][Full Text] [Related]
13. The C-terminal decapeptide of prothymosin α is responsible for its stimulatory effect on the functions of human neutrophils in vitro.
Samara P; Ioannou K; Neagu M; Arnogiannaki N; Ardavanis A; Voelter W; Tsitsilonis O
Int Immunopharmacol; 2013 Jan; 15(1):50-7. PubMed ID: 23201434
[TBL] [Abstract][Full Text] [Related]
14. Analysis of porcine peripheral blood mononuclear cells proteome by 2-DE and MS: analytical and biological variability in the protein expression level and protein identification.
Ramirez-Boo M; Garrido JJ; Ogueta S; Calvete JJ; Gómez-Díaz C; Moreno A
Proteomics; 2006 Apr; 6 Suppl 1():S215-25. PubMed ID: 16511813
[TBL] [Abstract][Full Text] [Related]
15. Prothymosin Alpha: A Novel Contributor to Estradiol Receptor Alpha-Mediated CD8
Passos LSA; Jha PK; Becker-Greene D; Blaser MC; Romero D; Lupieri A; Sukhova GK; Libby P; Singh SA; Dutra WO; Aikawa M; Levine RA; Nunes MCP; Aikawa E
Circulation; 2022 Feb; 145(7):531-548. PubMed ID: 35157519
[TBL] [Abstract][Full Text] [Related]
16. Increased generation of autologous tumor-reactive lymphocytes by anti-CD3 monoclonal antibody and prothymosin alpha.
Baxevanis CN; Spanakos G; Voutsas IF; Gritzapis AD; Tsitsilonis OE; Mamalaki A; Papamichail M
Cancer Immunol Immunother; 1999; 48(2-3):71-84. PubMed ID: 10414460
[TBL] [Abstract][Full Text] [Related]
17. Identification of prothymosin-alpha1, the necrosis-apoptosis switch molecule in cortical neuronal cultures.
Ueda H; Fujita R; Yoshida A; Matsunaga H; Ueda M
J Cell Biol; 2007 Mar; 176(6):853-62. PubMed ID: 17353361
[TBL] [Abstract][Full Text] [Related]
18. Prothymosin alpha-receptor associates with lipid rafts in PHA-stimulated lymphocytes.
Salgado FJ; Piñeiro A; Canda-Sánchez A; Lojo J; Nogueira M
Mol Membr Biol; 2005; 22(3):163-76. PubMed ID: 16096260
[TBL] [Abstract][Full Text] [Related]
19. Superoxide anion generation by human peripheral blood mononuclear cells in response to prothymosin alpha.
Aliverti A; Galaris D; Tsolas O
Arch Biochem Biophys; 1995 Aug; 321(1):108-14. PubMed ID: 7639508
[TBL] [Abstract][Full Text] [Related]
20. Prothymosin-α Variants Elicit Anti-HIV-1 Response via TLR4 Dependent and Independent Pathways.
Gusella GL; Teixeira A; Aberg J; Uversky VN; Mosoian A
PLoS One; 2016; 11(6):e0156486. PubMed ID: 27310139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]